Revised: 15 January 2026
About Medsafe
Safety Communications Archive
Archive of safety communications
This section contains links to previous safety communications. Please note that the information contained in these communications may have been superseded. Check the product information for your medicine or medical device for the current known safety information.
2024
| Publication date | Communication | Product Type | Topic | Update date |
|---|---|---|---|---|
| 16 October 2024 | Monitoring | Medicine | Update - Calcium channel blockers and the possible risk of new-onset eczema | |
| 8 August 2024 | Monitoring | Medicine | Direct acting oral anticoagulants and potential for patients to experience mood changes (monitoring closes February 2025) | 14 April 2025 |
| 9 July 2024 | Monitoring | Medicine | DPP-4 inhibitors and the possible risk of ileus | |
| 13 May 2024 | Alert | Medicine | Promethazine (oral): Do not use in children under 6 years of age due to the risk of psychiatric and central nervous system side effects | |
| 8 April 2024 | Alert | Medicine | Do not use NaturaCoco Moisturising Cream or Dok Apo Moisturiser Soothing Cream | |
| 8 April 2024 | Monitoring | Medicine | Calcium channel blockers and the possible risk of new-onset eczema | 16 October 2024 |
| 4 March 2024 | Alert | Medicine | Recent cases of lead poisoning with Ayurvedic Medicines | |
| 15 January 2024 | Monitoring | Medicine | DPP-4 inhibitors and the possible risk of ileus | 9 July 2024 |
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2010 - 2012
| Publication date | Topic |
|---|---|
| 17 April 2012 | Management of Patients with Metal on Metal Hip Implants |
| March 2012 | Update on Pradaxa (dabigatran etexilate) |
| 31 October 2011 | Pradaxa (dabigatran etexilate): Questions and Answers |
| 24 August 2011 | Vaccine adverse event information to be released to the Health Select Committee (PDF document, 112 KB, 12 pages) |
| 17 February 2011 | Questions and Answers on rosiglitazone (Avandia) |
| 11 October 2010 | Withdrawal of Sibutramine (Reductil) in New Zealand |
| 9 June 2010 | Graseby MS-Series Syringe Drivers - Further Extension of Deadline |
2005 - 2009
2000 - 2004
| Publication date | Topic |
|---|---|
| April 2004 | Oral Contraceptives and Hormone Replacement Therapy - Archive 1996 to 2004 |
| 15 October 2002 | The Use of Alcohol Based Skin Preparations in Operating Theatres |
| 19 June 2002 | Herbal Supplements Warning from Health Canada |
| 22 November 2000 | Finger Pricking Devices - Important Notice |
1990s
| Publication date | Topic |
|---|---|
| July 1999 | Amalgam and other Dental Filling Materials |
| November 1994 | Silicone Gel Breast Implants |
The history of safety communications – Early Warning System
Medsafe safety communications were initially developed as a joint project with the Australian Therapeutic Goods Administration (TGA) and called the trans-Tasman Early Warning System. Further information on this project can be found in the following links.
Consumers questions and answers on the early warning system
Healthcare professionals questions and answers on the early warning system
Audit of the first 12 months of the early warning system (PDF 350 KB, 14 pages)
Further information on the criteria used by Medsafe to decide when to publish a monitoring communication (PDF 224 KB, 9 pages)


Update - Possible
risk of hypothyroidism in infants exposed to iodine-containing contrast
agents


